Intelligence Β· Clinical Pipeline

Prime Medicine Pipeline

All ClinicalTrials.gov programs at Prime Medicine β€” phase, modality, and trial IDs.

Programs
8

Quick answer

Prime Medicine has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Bemarituzumab

    Prime Medicine

    Gastrointestinal Cancer

    phase 1 mab completed

    1 trial
  2. Cabiralizumab

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab completed

    1 trial
  3. FP-1039

    Prime Medicine

    Advanced Cancer

    phase 1 small molecule completed

    1 trial
  4. FPA008

    Prime Medicine

    Healthy

    phase 1 small molecule terminated

    1 trial
  5. FPA144

    Prime Medicine

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial
  6. FPA150

    Prime Medicine

    Breast Cancer

    phase 1 mab terminated

    1 trial
  7. FPT155

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab terminated

    1 trial
  8. PG-033

    Prime Medicine

    Lichen Simplex Chronicus

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Prime Medicine have?

8 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs